Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Operating Income 2009–2025
Celldex Therapeutics Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Celldex Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -84.4 M, a 34.58% increase year-over-year.
- Celldex Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -263.2 M, a 63.08% increase year-over-year.
- Celldex Therapeutics Inc. annual operating income for 2025 was -287.4 M, a 47.31% increase from 2024.
- Celldex Therapeutics Inc. annual operating income for 2024 was -195.1 M, a 26.23% increase from 2023.
- Celldex Therapeutics Inc. annual operating income for 2023 was -154.5 M, a 34.11% increase from 2022.
- Celldex Therapeutics Inc. annual operating income for 2022 was -115.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Celldex Therapeutics Inc. Operating Income — FAQ
Celldex Therapeutics Inc. (CLDX) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Celldex Therapeutics Inc.'s operating income?
Celldex Therapeutics Inc. (CLDX) reported operating income of -$287M for fiscal 2025.
Where can I see CLDX's operating income history?
The chart and table above show Celldex Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.